TVTX
Travere Therapeutics Inc
Price:  
14.92 
USD
Volume:  
1,101,182.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TVTX WACC - Weighted Average Cost of Capital

The WACC of Travere Therapeutics Inc (TVTX) is 7.8%.

The Cost of Equity of Travere Therapeutics Inc (TVTX) is 8.40%.
The Cost of Debt of Travere Therapeutics Inc (TVTX) is 5.50%.

Range Selected
Cost of equity 6.90% - 9.90% 8.40%
Tax rate 0.10% - 0.10% 0.10%
Cost of debt 4.00% - 7.00% 5.50%
WACC 6.3% - 9.3% 7.8%
WACC

TVTX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.67 0.91
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.90% 9.90%
Tax rate 0.10% 0.10%
Debt/Equity ratio 0.29 0.29
Cost of debt 4.00% 7.00%
After-tax WACC 6.3% 9.3%
Selected WACC 7.8%